末梢神経炎治療の世界市場レポート 2025年

末梢神経炎治療市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は5.0％で、23億6,000万米ドルに成長します。予測期間の成長は、治療選択肢の拡大、高齢者人口の増加、肥満率の上昇、HIV/エイズの流行、ジェネリック医薬品市場の成長、政府およびヘルスケア主導によるものと考えられます。この期間の主な動向としては、共同研究やパートナーシップ、技術の発展、糖尿病治療薬の上市の増加、個別化医療への注目の高まり、非薬物療法の開発、デジタルヘルスツールの統合などが挙げられます。

糖尿病の有病率の増加は、末梢神経炎治療市場の拡大を促進すると予想されます。糖尿病は、血糖（グルコース）レベルを適切に調整する身体の能力に影響を及ぼす慢性疾患です。糖尿病の罹患率の上昇は、座りがちなライフスタイル、不健康な食生活、肥満、高齢化、遺伝的素因などの要因に起因しています。末梢神経炎治療は、神経の痛みを和らげ、炎症を抑え、神経機能を高めることにより、生活の質を向上させ、合併症を予防することで、糖尿病患者をサポートする重要な役割を担っています。例えば、2023年11月、米国の非営利団体である米国糖尿病協会（American Diabetes Association）は、2022年に米国で約2,550万人が糖尿病と診断され、総人口の7.6％を占めると報告しました。その結果、糖尿病の有病率の増加が末梢神経炎治療市場の成長に拍車をかけています。

末梢神経炎治療市場の主要企業は、神経再生を促進し神経障害性疼痛を緩和する磁気末梢神経刺激（mPNS）などの革新的治療の開拓に注力しています。磁気末梢神経刺激は、磁場を用いて末梢神経を刺激する非侵襲的な神経調節技術であり、神経障害や筋骨格系障害などの症状における疼痛管理、神経再生、運動機能改善を支援します。例えば、2024年1月、米国の医療機器メーカーであるNeuralace Medical Inc.は、慢性の痛みを伴う糖尿病性神経障害（PDN）の治療に対するアクソン療法（mPNS）のFDA承認を発表しました。この治療法は、痛みを素早く、無痛で、非侵襲的に緩和するアプローチを提供します。臨床試験では、30日目の奏効率が72.3％、90日目の奏効率が81.4％であり、痛みやしびれの軽減に有効であることが実証されました。今回の承認は、疼痛管理における大きな進歩であり、患者に薬物療法の副作用を伴わない従来の治療に代わる選択肢を提供するものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界末梢神経炎治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の末梢神経炎治療市場：成長率分析
• 世界の末梢神経炎治療市場の実績：規模と成長, 2019-2024
• 世界の末梢神経炎治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界末梢神経炎治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の末梢神経炎治療市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬理学的療法
• 非薬物療法
• 世界の末梢神経炎治療市場：薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗うつ薬
• 抗けいれん薬
• 局所麻酔
• 鎮痛剤
• ステロイド
• その他の薬物クラス
• 世界の末梢神経炎治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• ドラッグストア
• 世界の末梢神経炎治療市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 糖尿病性末梢神経障害
• 化学療法誘発性末梢神経障害
• 特発性末梢神経障害
• その他の用途
• 世界の末梢神経炎治療市場、薬物療法の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鎮痛剤（鎮痛剤）
• 抗うつ薬
• 抗けいれん薬
• 外用薬
• 世界の末梢神経炎治療市場非薬物療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 理学療法
• 経皮的電気神経刺激（TENS）
• 鍼
• ライフスタイルと食生活の改善

第7章 地域別・国別分析

• 世界の末梢神経炎治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の末梢神経炎治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 末梢神経炎治療市場：競合情勢
• 末梢神経炎治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson（J&J）Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • GSK plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Takeda Pharmaceuticals & Co. Ltd.
• Eli Lilly and Co.
• Mallinckrodt Pharmaceuticals plc
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Astellas Pharma Inc.
• Sun Pharmaceutical Industries Ltd.
• Apotex Inc.
• Dr Reddys Laboratories Ltd.
• Cipla Inc.
• Amneal Pharmaceuticals LLC
• Lupin Ltd.
• Daiichi Sankyo Co. Ltd.
• Glenmark Pharmaceuticals Ltd.
• Cadila Pharmaceuticals Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 末梢神経炎治療市場2029：新たな機会を提供する国
• 末梢神経炎治療市場2029：新たな機会を提供するセグメント
• 末梢神経炎治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Peripheral neuritis is characterized by inflammation or damage to the peripheral nerves, resulting in symptoms such as pain, weakness, numbness, and tingling. It is commonly caused by factors such as diabetes, infections, toxins, or nutritional deficiencies. Treatment options include medications, physical therapy, lifestyle adjustments, and addressing underlying conditions.

The primary treatment approaches for peripheral neuritis include pharmacological and non-pharmacological therapies. Pharmacological treatments involve the use of medications such as pain relievers, anticonvulsants, and antidepressants to alleviate pain and enhance nerve function. These medications are categorized into antidepressants, anticonvulsants, local anesthetics, analgesics, steroids, and other drug classes. They are distributed through various channels, including hospital pharmacies, retail pharmacies, online pharmacies, and drug stores. These treatments are applied to conditions such as diabetic peripheral neuropathy, chemotherapy-induced peripheral neuropathy, idiopathic peripheral neuropathy, and others.

The peripheral neuritis treatment market research report is one of a series of new reports from The Business Research Company that provides peripheral neuritis treatment market statistics, including the peripheral neuritis treatment industry global market size, regional shares, competitors with the peripheral neuritis treatment market share, detailed peripheral neuritis treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the peripheral neuritis treatment industry. This peripheral neuritis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The peripheral neuritis treatment market size has grown strongly in recent years. It will grow from $1.84 billion in 2024 to $1.93 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth during the historic period can be attributed to rising healthcare expenditure, an increase in chronic diseases, the growing prevalence of conditions linked to peripheral neuritis, a higher rate of diabetes, and a growing aging population.

The peripheral neuritis treatment market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to the expanding range of treatment options, a rising geriatric population, increasing obesity rates, the prevalence of HIV/AIDS, the growth of the generic drug market, and government and healthcare initiatives. Key trends during this period include collaborations and partnerships, technological advancements, an increase in diabetic peripheral neuritis treatment product launches, a heightened focus on personalized medicine, the development of non-pharmacological therapies, and the integration of digital health tools.

The increasing prevalence of diabetes is expected to drive the expansion of the peripheral neuritis treatment market. Diabetes is a chronic condition that affects the body's ability to regulate blood sugar (glucose) levels properly. The rising incidence of diabetes can be attributed to factors such as sedentary lifestyles, unhealthy diets, obesity, aging populations, and genetic predisposition. Peripheral neuritis treatment plays a crucial role in supporting diabetic individuals by alleviating nerve pain, reducing inflammation, and enhancing nerve function, thereby improving quality of life and preventing complications. For example, in November 2023, the American Diabetes Association, a US-based non-profit organization, reported that approximately 25.5 million people in the U.S. were diagnosed with diabetes in 2022, representing 7.6% of the total population. Consequently, the increasing prevalence of diabetes is fueling the growth of the peripheral neuritis treatment market.

Leading companies in the peripheral neuritis treatment market are focusing on developing innovative treatments, such as magnetic peripheral nerve stimulation (mPNS), to promote nerve regeneration and alleviate neuropathic pain. Magnetic peripheral nerve stimulation is a non-invasive neuromodulation technique that uses magnetic fields to stimulate peripheral nerves, aiding in pain management, nerve regeneration, and motor function improvement in conditions such as neuropathy and musculoskeletal disorders. For instance, in January 2024, Neuralace Medical Inc., a US-based medical equipment manufacturer, announced FDA approval for Axon Therapy (mPNS) for the treatment of chronic painful diabetic neuropathy (PDN). This therapy offers a quick, painless, and non-invasive approach to pain relief. Clinical trials demonstrated a 72.3% responder rate at Day 30 and an 81.4% responder rate at Day 90, underscoring its effectiveness in reducing pain and numbness. This approval represents a significant advancement in pain management, providing patients with an alternative to traditional treatments without the side effects of medication.

In October 2024, Alkem Laboratories Limited, an India-based pharmaceutical company, partnered with Sonnet BioTherapeutics to develop, manufacture, and commercialize SON-080, a drug candidate for treating diabetic peripheral neuropathy (DPN) in India. Sonnet BioTherapeutics is a US-based biotechnology company specializing in oncology.

Major players in the peripheral neuritis treatment market are Pfizer Inc., Johnson & Johnson (J&J), AstraZeneca Plc, Novartis AG, GSK plc, Takeda Pharmaceuticals & Co. Ltd., Eli Lilly and Co., Mallinckrodt Pharmaceuticals plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Apotex Inc., Dr Reddys Laboratories Ltd., Cipla Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Daiichi Sankyo Co. Ltd., Glenmark Pharmaceuticals Ltd., Cadila Pharmaceuticals Ltd.

North America was the largest region in the peripheral neuritis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in peripheral neuritis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the peripheral neuritis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The peripheral neuritis treatment market consists of revenues earned by entities by providing services such as pharmacological treatment, physical therapy and rehabilitation, nutritional and dietary support, lifestyle management and patient education. The market value includes the value of related goods sold by the service provider or included within the service offering. The peripheral neuritis treatment market also includes sales of pain relievers, antidepressants, anticonvulsants, and corticosteroids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Peripheral Neuritis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peripheral neuritis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for peripheral neuritis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peripheral neuritis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Pharmacological Therapies; Non Pharmacological Therapies
• 2) By Drug Class: Anti-Depressants; Anticonvulsants; Local Anesthesia; Analgesics; Steroids; Other Drug Classes
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Drug Stores
• 4) By Application: Diabetic Peripheral Neuropathy; Chemotherapy-Induced Peripheral Neuropathy; Idiopathic Peripheral Neuropathy; Other Applications
• Subsegments:
• 1) By Pharmacological Therapies: Pain Relievers (Analgesics); Antidepressants; Anticonvulsants; Topical Medications
• 2) By Non-Pharmacological Therapies: Physical Therapy; Transcutaneous Electrical Nerve Stimulation (TENS); Acupuncture; Lifestyle And Dietary Modifications
• Companies Mentioned:Pfizer Inc.; Johnson & Johnson (J&J); AstraZeneca Plc; Novartis AG; GSK plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Peripheral Neuritis Treatment Market Characteristics

3. Peripheral Neuritis Treatment Market Trends And Strategies

4. Peripheral Neuritis Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Peripheral Neuritis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Peripheral Neuritis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Peripheral Neuritis Treatment Market Growth Rate Analysis
• 5.4. Global Peripheral Neuritis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Peripheral Neuritis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Peripheral Neuritis Treatment Total Addressable Market (TAM)

6. Peripheral Neuritis Treatment Market Segmentation

• 6.1. Global Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacological Therapies
• Non Pharmacological Therapies
• 6.2. Global Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anti-Depressants
• Anticonvulsants
• Local Anesthesia
• Analgesics
• Steroids
• Other Drug Classes
• 6.3. Global Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores
• 6.4. Global Peripheral Neuritis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diabetic Peripheral Neuropathy
• Chemotherapy-Induced Peripheral Neuropathy
• Idiopathic Peripheral Neuropathy
• Other Applications
• 6.5. Global Peripheral Neuritis Treatment Market, Sub-Segmentation Of Pharmacological Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Relievers (Analgesics)
• Antidepressants
• Anticonvulsants
• Topical Medications
• 6.6. Global Peripheral Neuritis Treatment Market, Sub-Segmentation Of Non-Pharmacological Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Therapy
• Transcutaneous Electrical Nerve Stimulation (TENS)
• Acupuncture
• Lifestyle And Dietary Modifications

7. Peripheral Neuritis Treatment Market Regional And Country Analysis

• 7.1. Global Peripheral Neuritis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Peripheral Neuritis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Peripheral Neuritis Treatment Market

• 8.1. Asia-Pacific Peripheral Neuritis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Peripheral Neuritis Treatment Market

• 9.1. China Peripheral Neuritis Treatment Market Overview
• 9.2. China Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Peripheral Neuritis Treatment Market

• 10.1. India Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Peripheral Neuritis Treatment Market

• 11.1. Japan Peripheral Neuritis Treatment Market Overview
• 11.2. Japan Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Peripheral Neuritis Treatment Market

• 12.1. Australia Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Peripheral Neuritis Treatment Market

• 13.1. Indonesia Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Peripheral Neuritis Treatment Market

• 14.1. South Korea Peripheral Neuritis Treatment Market Overview
• 14.2. South Korea Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Peripheral Neuritis Treatment Market

• 15.1. Western Europe Peripheral Neuritis Treatment Market Overview
• 15.2. Western Europe Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Peripheral Neuritis Treatment Market

• 16.1. UK Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Peripheral Neuritis Treatment Market

• 17.1. Germany Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Peripheral Neuritis Treatment Market

• 18.1. France Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Peripheral Neuritis Treatment Market

• 19.1. Italy Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Peripheral Neuritis Treatment Market

• 20.1. Spain Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Peripheral Neuritis Treatment Market

• 21.1. Eastern Europe Peripheral Neuritis Treatment Market Overview
• 21.2. Eastern Europe Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Peripheral Neuritis Treatment Market

• 22.1. Russia Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Peripheral Neuritis Treatment Market

• 23.1. North America Peripheral Neuritis Treatment Market Overview
• 23.2. North America Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Peripheral Neuritis Treatment Market

• 24.1. USA Peripheral Neuritis Treatment Market Overview
• 24.2. USA Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Peripheral Neuritis Treatment Market

• 25.1. Canada Peripheral Neuritis Treatment Market Overview
• 25.2. Canada Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Peripheral Neuritis Treatment Market

• 26.1. South America Peripheral Neuritis Treatment Market Overview
• 26.2. South America Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Peripheral Neuritis Treatment Market

• 27.1. Brazil Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Peripheral Neuritis Treatment Market

• 28.1. Middle East Peripheral Neuritis Treatment Market Overview
• 28.2. Middle East Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Peripheral Neuritis Treatment Market

• 29.1. Africa Peripheral Neuritis Treatment Market Overview
• 29.2. Africa Peripheral Neuritis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Peripheral Neuritis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Peripheral Neuritis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Peripheral Neuritis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Peripheral Neuritis Treatment Market Competitive Landscape
• 30.2. Peripheral Neuritis Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson (J&J) Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GSK plc Overview, Products and Services, Strategy and Financial Analysis

31. Peripheral Neuritis Treatment Market Other Major And Innovative Companies

• 31.1. Takeda Pharmaceuticals & Co. Ltd.
• 31.2. Eli Lilly and Co.
• 31.3. Mallinckrodt Pharmaceuticals plc
• 31.4. Viatris Inc.
• 31.5. Teva Pharmaceutical Industries Ltd.
• 31.6. Astellas Pharma Inc.
• 31.7. Sun Pharmaceutical Industries Ltd.
• 31.8. Apotex Inc.
• 31.9. Dr Reddys Laboratories Ltd.
• 31.10. Cipla Inc.
• 31.11. Amneal Pharmaceuticals LLC
• 31.12. Lupin Ltd.
• 31.13. Daiichi Sankyo Co. Ltd.
• 31.14. Glenmark Pharmaceuticals Ltd.
• 31.15. Cadila Pharmaceuticals Ltd.

32. Global Peripheral Neuritis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Peripheral Neuritis Treatment Market

34. Recent Developments In The Peripheral Neuritis Treatment Market

35. Peripheral Neuritis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Peripheral Neuritis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Peripheral Neuritis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Peripheral Neuritis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer